Pinglan Lu

496 total citations
8 papers, 341 citations indexed

About

Pinglan Lu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Pinglan Lu has authored 8 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in Pinglan Lu's work include Extracellular vesicles in disease (3 papers), Autophagy in Disease and Therapy (2 papers) and RNA modifications and cancer (2 papers). Pinglan Lu is often cited by papers focused on Extracellular vesicles in disease (3 papers), Autophagy in Disease and Therapy (2 papers) and RNA modifications and cancer (2 papers). Pinglan Lu collaborates with scholars based in China. Pinglan Lu's co-authors include Xuxia Wei, Guihua Chen, Huimin Yi, Yuling An, Xiaomeng Yi, Haijin Lv, Xin Sui, Yang Yang, Lijuan Li and Lijuan Li and has published in prestigious journals such as Experimental Cell Research, Advanced Science and Cell Death and Disease.

In The Last Decade

Pinglan Lu

7 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pinglan Lu China 5 248 123 69 49 38 8 341
Siou-Ling Tzeng Taiwan 10 230 0.9× 201 1.6× 24 0.3× 79 1.6× 54 1.4× 14 432
Li Yao China 10 200 0.8× 70 0.6× 83 1.2× 29 0.6× 52 1.4× 42 419
Marcela Hortová Kohoutková Czechia 11 93 0.4× 32 0.3× 35 0.5× 104 2.1× 51 1.3× 26 280
Subhojit Paul India 10 141 0.6× 113 0.9× 35 0.5× 29 0.6× 22 0.6× 36 293
Florian Brandes Germany 9 348 1.4× 226 1.8× 23 0.3× 50 1.0× 50 1.3× 16 461
Guan‐Sheng Liu United States 8 417 1.7× 198 1.6× 22 0.3× 26 0.5× 39 1.0× 10 501
Yichun He China 7 191 0.8× 53 0.4× 44 0.6× 41 0.8× 83 2.2× 9 305
Haijun Li China 10 176 0.7× 117 1.0× 24 0.3× 33 0.7× 19 0.5× 21 300
Krisztína Németh Hungary 11 138 0.6× 43 0.3× 46 0.7× 34 0.7× 16 0.4× 36 310
Tiaosi Xing United States 7 197 0.8× 81 0.7× 41 0.6× 43 0.9× 25 0.7× 17 378

Countries citing papers authored by Pinglan Lu

Since Specialization
Citations

This map shows the geographic impact of Pinglan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pinglan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pinglan Lu more than expected).

Fields of papers citing papers by Pinglan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pinglan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pinglan Lu. The network helps show where Pinglan Lu may publish in the future.

Co-authorship network of co-authors of Pinglan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Pinglan Lu. A scholar is included among the top collaborators of Pinglan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pinglan Lu. Pinglan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
3.
Lu, Pinglan, et al.. (2021). LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins. Annals of Translational Medicine. 9(21). 1621–1621. 11 indexed citations
4.
Wei, Xuxia, Xiaomeng Yi, Haijin Lv, et al.. (2020). MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy. Cell Death and Disease. 11(8). 657–657. 165 indexed citations
5.
6.
Lv, Haijin, Xuxia Wei, Xiaomeng Yi, et al.. (2020). High-dose ulinastatin to prevent late-onset acute renal failure after orthotopic liver transplantation. Renal Failure. 42(1). 137–145. 5 indexed citations
7.
Yi, Xiaomeng, Xuxia Wei, Haijin Lv, et al.. (2019). Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Experimental Cell Research. 383(2). 111454–111454. 110 indexed citations
8.
Wei, Xuxia, Yuling An, Xiaomeng Yi, et al.. (2015). [Application of plasmapheresis combined with hemofiltration in the treatment of severe liver disease in middle and late pregnancy].. PubMed. 95(44). 3607–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siou-Ling Tzeng Breakdown of academic impact, for papers by Li Yao Breakdown of academic impact, for papers by Marcela Hortová Kohoutková Breakdown of academic impact, for papers by Subhojit Paul Breakdown of academic impact, for papers by Florian Brandes Breakdown of academic impact, for papers by Guan‐Sheng Liu Breakdown of academic impact, for papers by Yichun He Breakdown of academic impact, for papers by Haijun Li Breakdown of academic impact, for papers by Krisztína Németh Breakdown of academic impact, for papers by Tiaosi Xing
Rankless by CCL
2026